Melissa W. Wachterman

Melissa W. Wachterman

Auto-generated profile, based on publicly available information

Melissa W. Wachterman

Section of General Internal Medicine (M.W.W.), Veterans Affairs Boston Health Care System, Boston, Massachusetts, USA; Center for Healthcare Organization and Implementation Research (M.W.W., E.B.W.), Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA; Department of Psychosocial Oncology and Palliative Care (M.W.W.), Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MWMelissa W. Wachterman
Melissa W. Wachterman
CPCorey Pilver
Corey Pilver
DSDawn Smith
Dawn Smith
MEMary Ersek
Mary Ersek
SLStuart R. Lipsitz
Stuart R. Lipsitz
NKNancy L. Keating
Nancy L. Keating
Most individuals in the United States die of conditions other than cancer.1 However, historically, efforts to improve end-of-life care have focused primarily on patients with cancer.2,3 More recently, there has been increasing recognition that high-quality end-of-life care is also critical for patients with serious illnesses other than cancer, particularly with the aging of the US population.

1 June 2018 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
MWMelissa W. Wachterman
Melissa W. Wachterman
SHSusan M. Hailpern
Susan M. Hailpern
NKNancy L. Keating
Nancy L. Keating
MTManjula Kurella Tamura
Manjula Kurella Tamura
AOAnn M. O’hAre
Ann M. O’hAre
Importance Patients with end-stage renal disease are less likely to use hospice services than other patients with advanced chronic illness. Little is known about the timing of hospice referral in this population and its association with health care utilization and costs. Objective To examine the association between hospice length of stay and health care utilization and costs at the end of life among Medicare beneficiaries who had received maintenance hemodialysis. Design, Setting, and Participants This cross-sectional observational study was conducted via the United States Renal Data System registry. Participants were all 770 191 hemodialysis patients in the registry who were enrolled in fee-for-service Medicare and died between January 1, 2000, and December 31, 2014. The dates of analysis were April 2016 to December 2017. Main Outcomes and Measures Hospital admission, intensive care unit (ICU) admission, and receipt of an intensive procedure during the last month of life; death in the hospital; and costs to the Medicare program in the last week of life. Results Among 770 191 patients, the mean (SD) age was 74.8 (11.0) years, and 53.7% were male. Twenty percent of cohort members were receiving hospice services when they died. Of these, 41.5% received hospice for 3 days or fewer. In adjusted analyses, compared with patients who did not receive hospice, those enrolled in hospice for 3 days or fewer were less likely to die in the hospital (13.5% vs 55.1%;P < .001) or to undergo an intensive procedure in the last month of life (17.7% vs 31.6%;P < .001) but had higher rates of hospitalization (83.6% vs 74.4%;P < .001) and ICU admission (54.0% vs 51.0%;P < .001) and similar Medicare costs in the last week of life ($10 756 vs $10 871;P = .08). Longer lengths of stay in hospice beyond 3 days were associated with progressively lower rates of utilization and costs, especially for those referred more than 15 days before death (35.1% hospitalized and 16.7% admitted to an ICU in the last month of life; the mean Medicare costs in the last week of life were $3221). Conclusions and Relevance Overall, 41.5% of hospice enrollees who had been treated with hemodialysis for their end-stage renal disease entered hospice within 3 days of death. Although less likely to die in the hospital and to receive an intensive procedure, these patients were more likely than those not enrolled in hospice to be hospitalized and admitted to the ICU, and they had similar Medicare costs. Without addressing barriers to more timely referral, greater use of hospice may not translate into meaningful changes in patterns of health care utilization, costs, and quality of care at the end of life in this population.

1 December 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MWMelissa W. Wachterman
Melissa W. Wachterman
SLStuart R. Lipsitz
Stuart R. Lipsitz
KLKarl A. Lorenz
Karl A. Lorenz
EMEdward R. Marcantonio
Edward R. Marcantonio
ZLZhonghe Li
Zhonghe Li
NKNancy L. Keating
Nancy L. Keating

1 April 2006 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
MWMelissa W. Wachterman
Melissa W. Wachterman
BSBenjamin D. Sommers
Benjamin D. Sommers
Background: End-of-life care poses a growing clinical and policy concern. Gender and marital status may play important roles in shaping end-of-life care. Objective: To examine gender and marital status differences across multiple end-of-life care outcomes: primary residence in the last year of life (LYL), place of death, hospice use, type of formal and informal caregivers, and primary payment source for end-of-life care. Design: Retrospective cohort study using bivariate analyses and multivariate logistic regression. Participants: A nationally representative sample of 12,771 individuals who died of natural causes, from the 1993 National Mortality Followback Survey. Results: After multivariate adjustment, the only gender differences in end-of-life care were that women were more likely to receive formal or informal care in the LYL and more likely to be on Medicaid. After adjustment, unmarried individuals (widowed, divorced/separated, and single) were more likely than married people to live their LYL and die in nursing homes, less likely to receive formal or informal care in the LYL, and more likely to be on Medicaid. Hospice use was low, with minimal gender and marital status differences. Conclusions: Marital status is a key variable mediating gender differences in end-of-life care. Unmarried individuals are less likely to receive help from informal caregivers—most notably because of the lack of spousal care—which may explain why they are more likely to end up in nursing homes. Clinicians need to be aware of the impact of marital status on endof- life care. Policymakers should consider that women will be disproportionately affected by policy changes in public financing for end-of-life care.

24 October 2019 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MWMelissa W. Wachterman
Melissa W. Wachterman
TLTarikwa Leveille
Tarikwa Leveille
NKNancy L. Keating
Nancy L. Keating
SSSteven R. Simon
Steven R. Simon
SWSushrut S. Waikar
Sushrut S. Waikar
BBBarbara Bokhour
Barbara Bokhour
Background: Conservative management, an approach to treating end-stage kidney disease without dialysis, while generally associated with shorter life expectancy than treatment with dialysis, is associated with fewer hospitalizations, better functional status and, potentially, better quality of life. Conservative management is a well-established treatment approach in a number of Western countries, including the United Kingdom (U.K.). In contrast, despite clinical practice guidelines in the United States (U.S.) recommending that nephrologists discuss all treatment options, including conservative management, with stage 4 and 5 chronic kidney disease patients, studies suggest that this rarely occurs. Therefore, we explored U.S. nephrologists’ approaches to decision-making about dialysis and perspectives on conservative management among older adults.Methods: We conducted a qualitative research study. We interviewed 20 nephrologists – 15 from academic centers and 5 from community practices – utilizing a semi-structured interview guide containing open-ended questions. Interview transcripts were analyzed using grounded thematic analysis in which codes were generated inductively and iteratively modified, and themes were identified. Transcripts were coded independently by two investigators, and interviews were conducted until thematic saturation.Results: Twenty nephrologists (85% white, 75% male, mean age 50) participated in interviews. We found that decision-making about dialysis initiation in older adults can create emotional burden for nephrologists. We identified four themes that reflected factors that contribute to this emotional burden including nephrologists’ perspectives that: 1) uncertainty exists about how a patient will do on dialysis, 2) the alternative to dialysis is death, 3) confronting death is difficult, and 4) patients do not regret initiating dialysis. Three themes revealed different decision-making strategies that nephrologists use to reduce this emotional burden: 1) convincing patients to “just do it” (i.e. dialysis), 2) shifting the decision-making responsibility to patients, and 3) utilizing time-limited trials of dialysis.Conclusions: A decisionnotto start dialysis and instead pursue conservative management can be emotionally burdensome for nephrologists for a number of reasons including clinical uncertainty about prognosis on dialysis and discomfort with death. Nephrologists’ attempts to reduce this burden may be reflected in different decision-making styles – paternalistic, informed, and shared decision-making. Shared decision-making may relieve some of the emotional burden while preserving patient-centered care.

6 April 2025 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MWMelissa W. Wachterman
Melissa W. Wachterman
SLStuart R. Lipsitz
Stuart R. Lipsitz
EBErin Beilstein-Wedel
Erin Beilstein-Wedel
WGWalid F. Gellad
Walid F. Gellad
KLKarl A. Lorenz
Karl A. Lorenz
NKNancy L. Keating
Nancy L. Keating